retatrutide weight loss retatrutide clinical trial results Retatrutide: A Multi-Receptor Approach to Management retatrutide fat loss clinical trial

A controlled clinical trial revealed that patients with GLP-1ARs therapy showed significant reductions in perception of all five basic tastes, scoring 29% lower on standardized tests like the Waterless Empirical Taste Test (WETT ) compared to controls

Weekly / Monthly Best results with regular sessions weekly for recovery, monthly for maintenance

FDA Warning: RISK OF THYROID C-CELL TUMORS FDA Warning: RISK FOR ILEUS (INTESTINAL BLOCKAGE) (FDA 09/22/2023) References: Buckley ST et al (2018): Transcellular stomach absorption of a derivative glucagon-like peptide-1 receptor agonist

It was just a research project

Safety Overall, liraglutide was well tolerated and no safety concerns were identified